Berlin Heart EXCOR and ACTION post-approval surveillance study report

Keyphrases

• Improved Outcomes 100%
• Post-approval Changes 100%
• Surveillance Studies 100%
• Berlin Heart 100%
• Cardiac Therapy 100%
• EXCOR 60%
• North America 20%
• Ventricular Assist Device 20%
• Postmarket 20%
• Pediatric 10%
• Patient Care 10%
• Adverse Events 10%
• Over 40 10%
• Congenital Heart Disease 10%
• Stroke Incidence 10%
• Anticoagulant Therapy 10%
• Health Practices 10%
• Body Surface Area 10%
• Device Implantation 10%
• Major Bleeding 10%
• Historical Cohort 10%
• Collaborative Learning 10%
• Learning Collaborative 10%
• Biventricular Assist Device 10%
• Support Profile 10%
• Interagency Registry for Mechanically Assisted Circulatory Support 10%
• Bivalirudin 10%
• Pediatric Circulatory Support 10%
• Pediatric Heart Failure 10%
• Humanitarian Device Exemption 10%
• Anticoagulation Strategy 10%
• Pump Exchange 10%
• Heart Failure Programmes 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Failure 100%
• Adverse Event 100%
• Implant 100%
• Bleeding 100%
• Congenital Heart Disease 100%
• Anticoagulation Therapy 100%
• Bivalirudin 100%

Medicine and Dentistry

• Ventricular Assist Device 100%
• Pediatrics 25%
• Assisted Circulation 16%
• Collaborative Learning 16%
• Adverse Event 8%
• Implant 8%
• Heart Failure 8%
• Patient Care 8%
• Apoplexy 8%
• Persistent Truncus Arteriosus 8%
• Body Surface 8%
• Anticoagulant Therapy 8%
• Anticoagulation 8%
• Major Bleeding 8%
• Bivalirudin 8%